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ABSTRACT
Isolated basilar artery stenosis (BAS) is a rare etiology of ischemic neurologic conditions. 
First-line treatment of symptomatic stenosis is typically medical therapy as outlined in 
the Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) trial and the Stenting 
versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial.1,2 
We present the case of a male in his 60s with isolated BAS who failed maximal medical 
treatment but experienced a decrease in transient ischemic attacks and acute ischemic 
stroke occurrences after angioplasty and stenting. 
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Isolated basilar artery stenosis (BAS) is a rare etiology 
of transient ischemic attack (TIA) and acute ischemic 
stroke (AIS), accounting for only 1.43% of cases.3 The 
condition presents with a range of symptoms and 
rapidly progresses in severity. Multiple TIAs preceded 
infarction in certain patients with BAS, and in 60% of 
those cases, a posterior circulation stroke occurred 
two weeks after the initial TIA.4 Further evidence of 
the need for appropriate management is that neuro-
logic state after the onset of symptoms with BAS has 
the potential to significantly impact the long-term 
prognosis of patients.9 First-line medical manage-
ment of symptomatic BAS is typically medical thera-
py, as outlined in the Warfarin–Aspirin Symptomatic 
Intracranial Disease (WASID) trial and the Stenting 
versus Aggressive Medical Therapy for Intracranial 
Arterial Stenosis (SAMMPRIS) trial.1,2 Although studies 
have detailed the management of BAS, it has mainly 
been described in the context of diffuse intracranial 
atherosclerosis.5,6,7,8,9 Management of BAS in an iso-
lated scenario without the risk factors posed by the 
presence of atherosclerotic disease elsewhere has not 
been widely reported to our knowledge. We present 
the case of a male in his 60s with isolated BAS who 
failed maximal medical treatment but experienced a 
decrease in TIA and AIS occurrences after angioplasty 
and stenting.
CASE REPORT
Our patient is a male in his 60s who presented with 
complaints of two episodes of left-sided hemiparesis. 
Symptoms resolved spontaneously after 10 minutes, 
and the patient was stable upon admission. The 
patient had no pertinent past medical history or prior 
ischemic events. He denied tobacco use. Computed 
tomography angiography (CTA)  showed the anterior 
cerebral, anterior communicating, middle cerebral, 
posterior cerebral, and right communicating arteries 
patent with minimal atherosclerosis. The left commu-
nicating artery was not visualized. CTA also showed 
patent dural sinuses and internal carotid arteries. 
High-grade basilar artery stenosis within its proximal 
mid-course was visualized on an angiogram (Figure 
1). The patient was admitted on suspicion of a tran-
sient ischemic attack related to basilar artery stenosis. 
He was started on a loading dose of Plavix 300 mg 
followed by Plavix 75 mg, Atorvastatin 80 mg, and 
Aspirin 325 mg daily per SAMMPRIS protocol. Nation-
al Institutes of Health (NIH) stroke scale score was 
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determined to be 0. The patient had 
no acute events overnight, and he was 
discharged on a regimen of Aspirin 
325 mg daily, Plavix 75 mg daily, and 
Atorvastatin 80 mg daily. 24 days later 
the patient presented with right upper 
extremity weakness. He denied med-
ication nonadherence. CTA indicated 
>90% basilar artery stenosis. Magnetic 
resonance imaging (MRI) visualized 
an acute left cerebellar hemisphere 
infarct. Treatment teams determined 
that an eventual cerebral angiogram 
with angioplasty of the basilar artery 
would be beneficial. Soon after, the 
patient developed left-sided numb-
ness and dizziness. MRI demonstrated 
a stroke in the inferior basilar artery territory. Inter-
ventional radiology (IR) decided to proceed with 
angioplasty. Post-procedure, cerebral angiogram 
showed a 50% short segment dissection in the region 
of the stenosis. IR then proceeded with angioplasty 
and neuroform atlas stent placement. Repeat cerebral 
angiogram demonstrated minimal residual BAS. The 
patient remained stable post-procedure. All cerebral 
arteries were visualized as patent on CTA (Figure 2) 
when the patient came in once more for concern over 
forearm tingling. It was determined his symptoms 
could not be explained in the setting of normal CTA 
of the head and neck. After this initial post-operative 
visit, the patient did not return for any neurological 
issues.
DISCUSSION
Many studies discussing the management of BAS 
are in the context of coexisting cerebral or vertebral 
FIGURE 1. Angiogram showing >90% BAS.
FIGURE 2.  CTA demonstrating improvement in basi-
lar artery patency.
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artery atherosclerosis.5,6,7,8,9 Our patient’s case draws 
attention to the management of isolated BAS. The 
patient experienced an infarction while remaining 
adherent to the first-line medical treatment of BAS 
outlined in the SAMMPRIS protocol. Due to the 
failure of medical management, angioplasty of the 
basilar artery was the initial next step. Post-proce-
dure, however, dissection in the region of the steno-
sis visualized on angiogram lead IR to proceed with 
basilar artery angioplasty and stent placement. The 
patient has remained stable with no incidents of TIA 
or AIS since then. Despite its efficacy in our patient, 
stent placement is not considered to be a first-line 
treatment option of BAS. In the SAMMPRIS trial, it 
was found that medical management is more effec-
tive than stent implantation in treating intracranial 
arterial stenosis.2  This was concluded due to the 
increased risk of stroke post-stent placement and 
the efficacy of maximal medical therapy in decreas-
ing stroke risk.2  It was discussed how the presence 
of high-grade stenosis and acute symptoms could 
indicate the presence of unstable plaque.2 This 
unstable plaque could then predispose patients to 
periprocedural embolism in the distal arterial circu-
lation.2 This is of concern as embolism arising from 
arterial circulation is the most prevalent cause of 
stroke in patients with isolated BAS.3 In our patient, 
there was no incidence of periprocedural embolism 
or arterially derived embolism post-stent placement. 
This favorable outcome may be associated with the 
fact that CTA consistently visualized patent cerebral 
and vertebral circulation. Minimal atherosclerosis 
visualized in the vasculature, excluding the basilar 
artery, may have decreased the risk of arterially 
derived embolism associated with stent placement. 
Furthermore, the presence of collateral arterial circu-
lation is strongly associated with a better prognosis 
in general for patients with symptomatic isolated 
basilar artery stenosis.3 Another factor that may have 
contributed to the positive outcome in our patient is 
the location of the BAS.  Stenosis of the basilar artery 
mid area is typically associated with poor prognosis 
in isolated BAS in comparison to other locations.3 Our 
patient’s stenosis of the basilar artery was located in 
the proximal mid-course.
CONCLUSION
In the absence of diffuse atherosclerosis and no per-
tinent past medical history, our patient had a positive 
response to angioplasty and stenting after failing 
maximal medical treatment. While the current litera-
ture is in favor of medical management, our patient’s 
case suggests that stenting can have a positive out-
come in decreasing ischemic occurrences associated 
with isolated BAS.
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